Standout Papers

Combination strategies with PD-1/PD-L1 b... 2016 2026 2019 2022 827
  1. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022)
    Ming Yi, Xiaoli Zheng et al. Molecular Cancer
  2. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 (2019)
    Shuang Qin, Linping Xu et al. Molecular Cancer
  3. Notch signaling pathway: architecture, disease, and therapeutics (2022)
    Wanling Lin, Yaling Long et al. Signal Transduction and Targeted Therapy
  4. Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors (2018)
    Ming Yi, Dechao Jiao et al. Molecular Cancer
  5. The CXCL8-CXCR1/2 pathways in cancer (2016)
    Qian Liu, Anping Li et al. Cytokine & Growth Factor Reviews
  6. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment (2019)
    Ming Yi, Dechao Jiao et al. Molecular Cancer
  7. Regulation of PD-L1 expression in the tumor microenvironment (2021)
    Ming Yi, Mengke Niu et al. Journal of Hematology & Oncology
  8. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy (2019)
    Anping Li, Ming Yi et al. Journal of Hematology & Oncology
  9. CD44 as a tumor biomarker and therapeutic target (2020)
    Hanxiao Xu, Mengke Niu et al. Experimental Hematology and Oncology
  10. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy (2022)
    Yuze Wu, Ming Yi et al. Molecular Cancer
  11. Tumor organoids: applications in cancer modeling and potentials in precision medicine (2022)
    Hanxiao Xu, Dechao Jiao et al. Journal of Hematology & Oncology
  12. Recent advances in targeted strategies for triple-negative breast cancer (2023)
    Shuangli Zhu, Yuze Wu et al. Journal of Hematology & Oncology
  13. Targeting cytokine and chemokine signaling pathways for cancer therapy (2024)
    Ming Yi, Tianye Li et al. Signal Transduction and Targeted Therapy
  14. Exploiting innate immunity for cancer immunotherapy (2023)
    Ming Yi, Tianye Li et al. Molecular Cancer
  15. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021 (2025)
    Tianye Li, Haoxiang Zhang et al. Journal of Hematology & Oncology
  16. The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy (2025)
    Wenyang Zhang, Kongming Wu et al. Molecular Cancer

Immediate Impact

3 by Nobel laureates 15 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Hypoxia-tropic delivery of nanozymes targeting transferrin receptor 1 for nasopharyngeal carcinoma radiotherapy sensitization
2025 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
7 intermediate papers

Works of Kongming Wu being referenced

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
2023
Exploiting innate immunity for cancer immunotherapy
2023 Standout
and 8 more

Author Peers

Author Last Decade Papers Cites
Kongming Wu 7710 7216 3996 180 15.6k
Dean W. Felsher 9465 4543 2388 175 15.5k
Dihua Yu 10663 8892 2274 238 18.5k
Eli Pikarsky 8612 4870 3496 132 17.4k
Øystein Fodstad 8025 5526 2569 305 14.6k
Rolf A. Brekken 9184 6330 3395 270 19.0k
Matilde Todaro 8031 9173 3410 136 16.1k
Giorgio Stassi 8994 8848 3817 174 17.6k
Elda Tagliabue 6694 5306 2462 255 12.7k
Arne Östman 9650 4515 2825 165 16.5k
Corazon D. Bucana 8139 4585 1963 145 13.7k

All Works

Loading papers...

Rankless by CCL
2026